Clinical studies recruiting near Lebanon

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

KEYMAKER-U01 Substudy 01A: Efficacy and Safety Study of Pembrolizumab (MK-3475) With or Without Chemotherapy When Used W
Phase 1/Phase 2 · Dartmouth Hitchcock Medical Center ( Site 0016) · Merck Sharp & Dohme LLC · NCT04165070 This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide W
Phase 3 · Tennessee Oncology, PLLC - Lebanon · Pfizer · NCT07028853 Asleep Fiberoptic vs Direct Laryngoscopy Effect on Hemodynamic Stability Using Opioid Free Anesthesia Induction
NA · American University of Beirut Medical Center · NCT06487988 24BRO681 : Alternating Gnp and mFOLFIRINOX for BR-PDAC
Phase 2 · Dartmouth-Hitchcock Medical Center · Dartmouth-Hitchcock Medical Center · NCT07043270 Internet Based Psychological Support
NA · Dartmouth-Hitchcock Medical Center · Dartmouth-Hitchcock Medical Center · NCT02726061 MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Wi
Phase 2 · Dartmouth Hitchcock Medical Center/Dartmouth Cancer Center · National Cancer Institute (NCI) · NCT05564390 Trajectories of Recovery After Intravenous Propofol Versus Inhaled VolatilE Anesthesia Trial
NA · Dartmouth Hitchcock Medical Center · Washington University School of Medicine · NCT05991453 A Study of Roxadustat to Treat Anemia in Children and Teenagers With Chronic Kidney Disease
Phase 3 · Astellas Pharma Global Development, Inc. · NCT05970172 Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed
Phase 3 · Dartmouth Hitchcock Medical Center/Dartmouth Cancer Center · National Cancer Institute (NCI) · NCT06172296 Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small C
Phase 3 · Dartmouth Hitchcock Medical Center/Dartmouth Cancer Center · NRG Oncology · NCT05624996 M-Vizion™ Macroscopic Radiographic Study
Phase N/A · Dartmouth Health · Medacta USA · NCT05721859 Very Early Intensive Treatment of Infants Living With HIV to Achieve HIV Remission
Phase 1/Phase 2 · National Institute of Allergy and Infectious Diseases (NIAID · NCT02140255 A Study of Lower Radiotherapy Dose to Treat Children With CNS Germinoma
Phase 2 · Dartmouth Hitchcock Medical Center/Dartmouth Cancer Center · Children's Oncology Group · NCT06368817 Intravitreal Adalimumab Versus Subcutaneous Adalimumab in Non-infectious Uveitis
Phase 2 · American University of Beirut Medical Center · NCT02706704 A Study to Test the Addition of the Drug Cabozantinib to Chemotherapy in Patients With Newly Diagnosed Osteosarcoma
Phase 2/Phase 3 · Dartmouth Hitchcock Medical Center/Dartmouth Cancer Center · National Cancer Institute (NCI) · NCT05691478 Symbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer
Phase 1/Phase 2 · Tennessee Oncology, PLLC - Lebanon · Pfizer · NCT07421700 Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer
Phase 3 · Clinical Study Site · Summit Therapeutics · NCT07228832 Testing the Addition of a New Anti-cancer Drug, M3814 (Peposertib), to the Usual Radiotherapy in Patients With Locally A
Phase 1/Phase 2 · Dartmouth Hitchcock Medical Center/Dartmouth Cancer Center · National Cancer Institute (NCI) · NCT04172532 Safety and Tolerability Study of ST-503 for Refractory Pain Due to Peripheral Neuropathy (Small Fiber Predominant, SFN)
Phase 1/Phase 2 · Dartmouth Hitchcock Medical Center · Sangamo Therapeutics · NCT06980948 Individualized Dose Escalation of 5-FU for Gastrointestinal Cancer
NA · Dartmouth-Hitchcock Medical Center · Dartmouth-Hitchcock Medical Center · NCT05780684 Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS
Phase 3 · Dartmouth-Hitchcock Medical Center · Eli Lilly and Company · NCT06890598 Quality of Pediatric Resuscitation in a Multicenter Collaborative
Phase N/A · Dartmouth Hitchcock Medical Center · Children's Hospital of Philadelphia · NCT02708134 A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT
Phase 2 · Dartmouth Hitchcock Medical Center/Dartmouth Cancer Center · Children's Oncology Group · NCT04322318 A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previ
Phase 3 · Tennessee Oncology, PLLC - Lebanon · Pfizer · NCT07144280 Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcera
Phase 3 · Dartmouth-Hitchcock Medical Center · Eli Lilly and Company · NCT06937086 A Study to Evaluate the Safety and Efficacy of a Single Dose of RABI-767 in Participants With Acute Pancreatitis
Phase 2 · Dartmouth Hitchcock Medical Center · Panafina, Inc. · NCT06080789 Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
Phase 3 · Dartmouth Hitchcock Medical Center/Dartmouth Cancer Center · NRG Oncology · NCT05946213 ILY Robotic System vs Manual Flexible Ureteroscopy for Kidney Stone Treatment
NA · Albert El Hajj · NCT06996587 Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Ca
Phase N/A · Dartmouth-Hitchcock Medical Center · Duke University · NCT04278404 International Chronic Myeloid Leukemia Pediatric Study
Phase N/A · Poitiers University Hospital · NCT01281735

Look up another city

Look up another condition